News
RGC
24.00
+1.44%
0.34
Regencell Bioscience Holdings Ltd trading resumes
TipRanks · 3d ago
Regencell Bioscience Holdings Ltd trading halted, volatility trading pause
TipRanks · 3d ago
Regencell Bioscience falls -7.9%
TipRanks · 3d ago
Weekly Report: what happened at RGC last week (0302-0306)?
Weekly Report · 3d ago
Regencell Bioscience: Extended Lock-Up Creates Significant Upside Potential
Seeking Alpha · 6d ago
Weekly Report: what happened at RGC last week (0223-0227)?
Weekly Report · 03/02 09:41
Weekly Report: what happened at RGC last week (0216-0220)?
Weekly Report · 02/23 09:41
Weekly Report: what happened at RGC last week (0209-0213)?
Weekly Report · 02/16 09:41
Regencell announces one-year extension to insider lock-up commitments
Seeking Alpha · 02/13 16:08
Regencell Bioscience rises 18.2%
TipRanks · 02/13 15:06
Regencell Bioscience Extends Insider Stock Lock-Up to April 2027
TipRanks · 02/13 14:47
Most and least shorted mid-to mega-cap healthcare stocks in January
Seeking Alpha · 02/13 14:35
Weekly Report: what happened at RGC last week (0202-0206)?
Weekly Report · 02/09 09:42
Largest borrow rate increases among liquid names
TipRanks · 02/03 13:45
Regencell Bioscience rises 11.6%
TipRanks · 02/02 15:05
Largest borrow rate increases among liquid names
TipRanks · 02/02 13:45
Weekly Report: what happened at RGC last week (0126-0130)?
Weekly Report · 02/02 09:41
Regencell Bioscience rises 15.4%
TipRanks · 01/27 15:00
Regencell Bioscience deals with struggling business, yet shares surge, WSJ says
TipRanks · 01/27 11:40
Regencell Bioscience falls -10.9%
TipRanks · 01/26 15:06
More
Webull provides a variety of real-time RGC stock news. You can receive the latest news about Regencell Bioscience Holdings Ltd through multiple platforms. This information may help you make smarter investment decisions.
About RGC
Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.